In the 174 tested ESCC patients and 189 normal controls, the serum levels of eotaxin and IP‐10 were significantly higher in patients than in normal controls (p = 0.0038, 0.0031). The gene discussed is CXCL10; the disease is esophageal squamous cell carcinoma.